(JNS-Algemeiner) Stem cell treatment developed by Israeli company BrainStorm Cell Therapeutics has been designated by the U.S. FDA as a "fast-track" treatment of ALS, also known as Lou Gehrig's Disease, which sees 5,600 new cases in the U.S. each year.
2014-10-13 00:00:00Full ArticleBACK Visit the Daily Alert Archive